{"entity":{"type":"insider","cik":"0001834833","url":"/insider/0001834833","json_url":"/insider/0001834833.json","name":"Harding Thomas C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":24,"first":"2020-12-07","last":"2022-11-03","span_basis":"filed_date"},"name_variants":[{"name":"Harding Thomas C.","source":"filing","n_filings":24,"first_seen":"2020-12-07","last_seen":"2022-11-03"}],"transactions":[{"id":6291474,"accession":"0000899243-22-034896","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-034896","line_url":"/filing/0000899243-22-034896","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1766.0,"shares_display":"1,766","price_per_share":0.9828928652321631,"price_display":"0.98","price_state":"stated","total_value":1735.7888,"total_display":"1,735.79","total_whole":"1,736","shares_owned_after":19487.0,"shares_owned_after_display":"19,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider","n_lines":3},{"id":6561004,"accession":"0000899243-22-032655","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032655","line_url":"/filing/0000899243-22-032655#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6.0,"shares_display":"6","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":7.74,"total_display":"7.74","total_whole":"8","shares_owned_after":3683.0,"shares_owned_after_display":"3,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6945136,"accession":"0000899243-22-030419","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-030419","line_url":"/filing/0000899243-22-030419","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":1939.2,"total_display":"1,939.20","total_whole":"1,939","shares_owned_after":17816.0,"shares_owned_after_display":"17,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider","n_lines":2},{"id":6236127,"accession":"0000899243-22-027574","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-027574","line_url":"/filing/0000899243-22-027574","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1809.0,"shares_display":"1,809","price_per_share":1.4609914870093974,"price_display":"1.46","price_state":"stated","total_value":2642.9336,"total_display":"2,642.93","total_whole":"2,643","shares_owned_after":16364.0,"shares_owned_after_display":"16,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider","n_lines":3},{"id":6588578,"accession":"0000899243-22-025333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-025333","line_url":"/filing/0000899243-22-025333#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7.0,"shares_display":"7","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":18.97,"total_display":"18.97","total_whole":"19","shares_owned_after":3234.0,"shares_owned_after_display":"3,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-06","scope":"insider"},{"id":6714210,"accession":"0000899243-22-020948","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020948","line_url":"/filing/0000899243-22-020948","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1722.0,"shares_display":"1,722","price_per_share":0.6424873403019744,"price_display":"0.64","price_state":"stated","total_value":1106.3632,"total_display":"1,106.36","total_whole":"1,106","shares_owned_after":14720.0,"shares_owned_after_display":"14,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider","n_lines":2},{"id":6364700,"accession":"0000899243-22-016296","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-016296","line_url":"/filing/0000899243-22-016296","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1776.0,"shares_display":"1,776","price_per_share":1.9698,"price_display":"1.97","price_state":"stated","total_value":3498.3648,"total_display":"3,498.36","total_whole":"3,498","shares_owned_after":13328.0,"shares_owned_after_display":"13,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider","n_lines":3},{"id":6713545,"accession":"0000899243-22-013752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-013752","line_url":"/filing/0000899243-22-013752#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7.0,"shares_display":"7","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":18.62,"total_display":"18.62","total_whole":"19","shares_owned_after":2831.0,"shares_owned_after_display":"2,831","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":6669902,"accession":"0000899243-22-009060","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-009060","line_url":"/filing/0000899243-22-009060","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7826.0,"shares_display":"7,826","price_per_share":1.866,"price_display":"1.87","price_state":"stated","total_value":14603.316,"total_display":"14,603.32","total_whole":"14,603","shares_owned_after":11654.0,"shares_owned_after_display":"11,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider","n_lines":4},{"id":6442849,"accession":"0000899243-22-004571","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-004571","line_url":"/filing/0000899243-22-004571","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2118.0,"shares_display":"2,118","price_per_share":1.939644523135033,"price_display":"1.94","price_state":"stated","total_value":4108.1671,"total_display":"4,108.17","total_whole":"4,108","shares_owned_after":6734.0,"shares_owned_after_display":"6,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider","n_lines":3},{"id":6290250,"accession":"0000899243-22-000494","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-000494","line_url":"/filing/0000899243-22-000494#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7.0,"shares_display":"7","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":19.25,"total_display":"19.25","total_whole":"19","shares_owned_after":1551.0,"shares_owned_after_display":"1,551","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":4709912,"accession":"0000899243-21-046769","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-046769","line_url":"/filing/0000899243-21-046769","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":444.0,"total_display":"444.00","total_whole":"444","shares_owned_after":5395.0,"shares_owned_after_display":"5,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-03","scope":"insider","n_lines":2},{"id":5526079,"accession":"0000899243-21-042704","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-042704","line_url":"/filing/0000899243-21-042704","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1744.0,"shares_display":"1,744","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":7935.2,"total_display":"7,935.20","total_whole":"7,935","shares_owned_after":5255.0,"shares_owned_after_display":"5,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider","n_lines":3},{"id":5038548,"accession":"0000899243-21-039208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-039208","line_url":"/filing/0000899243-21-039208#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6.0,"shares_display":"6","price_per_share":4.41,"price_display":"4.41","price_state":"stated","total_value":26.46,"total_display":"26.46","total_whole":"26","shares_owned_after":1412.0,"shares_owned_after_display":"1,412","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-05","scope":"insider"},{"id":4267364,"accession":"0000899243-21-035149","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-035149","line_url":"/filing/0000899243-21-035149","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":723.72,"total_display":"723.72","total_whole":"724","shares_owned_after":3563.0,"shares_owned_after_display":"3,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":4451339,"accession":"0000899243-21-031444","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-031444","line_url":"/filing/0000899243-21-031444","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1740.0,"shares_display":"1,740","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":8386.8,"total_display":"8,386.80","total_whole":"8,387","shares_owned_after":3423.0,"shares_owned_after_display":"3,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider","n_lines":3},{"id":5328097,"accession":"0000899243-21-027516","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-027516","line_url":"/filing/0000899243-21-027516#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26.0,"shares_display":"26","price_per_share":5.79,"price_display":"5.79","price_state":"stated","total_value":150.54,"total_display":"150.54","total_whole":"151","shares_owned_after":1272.0,"shares_owned_after_display":"1,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider"},{"id":5031055,"accession":"0000899243-21-021852","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-021852","line_url":"/filing/0000899243-21-021852","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138.0,"shares_display":"138","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":776.94,"total_display":"776.94","total_whole":"777","shares_owned_after":1725.0,"shares_owned_after_display":"1,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":4404894,"accession":"0000899243-21-018277","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-018277","line_url":"/filing/0000899243-21-018277","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1879.0,"shares_display":"1,879","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":10409.66,"total_display":"10,409.66","total_whole":"10,410","shares_owned_after":1575.0,"shares_owned_after_display":"1,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider","n_lines":3},{"id":5391625,"accession":"0000899243-21-011578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-011578","line_url":"/filing/0000899243-21-011578","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9354.0,"shares_display":"9,354","price_per_share":5.992124224930511,"price_display":"5.99","price_state":"stated","total_value":56050.33,"total_display":"56,050.33","total_whole":"56,050","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-15","scope":"insider","n_lines":2},{"id":4653350,"accession":"0000899243-21-009501","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-009501","line_url":"/filing/0000899243-21-009501","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":307.0,"shares_display":"307","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":1931.03,"total_display":"1,931.03","total_whole":"1,931","shares_owned_after":7367.0,"shares_owned_after_display":"7,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":3},{"id":5087567,"accession":"0000899243-21-007382","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-007382","line_url":"/filing/0000899243-21-007382","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":852.0,"shares_display":"852","price_per_share":8.17,"price_display":"8.17","price_state":"stated","total_value":6960.84,"total_display":"6,960.84","total_whole":"6,961","shares_owned_after":2687.0,"shares_owned_after_display":"2,687","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-19","scope":"insider","n_lines":2},{"id":4973260,"accession":"0000899243-21-004678","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-004678","line_url":"/filing/0000899243-21-004678","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001834833","owner_name":"Harding Thomas C.","owner_display_name":"Harding Thomas C.","owner_url":"/insider/0001834833","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5248.0,"shares_display":"5,248","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":41826.56,"total_display":"41,826.56","total_whole":"41,827","shares_owned_after":7126.0,"shares_owned_after_display":"7,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-02-02|4973257","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":52,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":24,"first_seen":"2020-12-07","last_seen":"2022-11-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001834833","retrieved_at":"2026-08-26T19:44:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}